Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Enzyme shreds Alzheimer's protein
Slashdot It! Slashdot Enzyme shreds Alzheimer's protein
Submit to Reddit Submit Enzyme shreds Alzheimer's protein to Reddit
Reading: Enzyme shreds Alzheimer's proteinTwitter This Reading: Enzyme shreds Alzheimer's proteinTwitter Enzyme shreds Alzheimer's protein
Add to Facebook Add Enzyme shreds Alzheimer's protein to Facebook

Enzyme shreds Alzheimer's protein

September 21, 2006

An enzyme found naturally in the brain snips apart the protein that forms the sludge called amyloid plaque that is one of the hallmarks of Alzheimer's disease (AD), researchers have found. They said their findings in mice suggest that the protein, called Cathepsin B (CatB), is a key part of a protective mechanism that may fail in some forms of AD. Also, they said their findings suggest that drugs to enhance CatB activity could break down amyloid deposits, counteracting one of the central pathologies of AD.

Li Gan and colleagues published their findings in the September 21, 2006, issue of the journal Neuron, published by Cell Press.




Their experiments were prompted by previous studies showing that the cysteine protease CatB-an enzyme that snips apart proteins-closely associated with the amyloid-ß (Aß) protein that forms the amyloid plaques, a hallmark of AD. However, those studies had not determined whether CatB was "good" or "bad"-that is, whether it acted to produce Aß from a longer protein, called amyloid precursor protein (APP), or whether it broke down Aß.

In their experiments, Gan and colleagues determined that CatB was the latter-breaking down Aß, apparently to enable other enzymes to further degrade the protein for the cell's protein "garbage deposal" system.

They found that knocking out the CatB gene increased plaque deposition in a mouse model of AD in which mice expressed the human form of APP. They also found that CatB tended to accumulate within amyloid plaques and that it acted to reduce Aß levels in neurons. And they found that introducing a pathological form of Aß, called Aß1-42, into neurons increased CatB in young and middle-aged mice with human APP, but not old mice. "Thus, upregulation of CatB may represent a protective mechanism that fails with aging," wrote the researchers, and such failure may play a role in late-onset sporadic AD.

Their test tube studies showed that CatB biochemically degrades Aß by snipping one end of the protein, called the C-terminal end. What's more, the enzyme also degrades the long strings of Aß that form amyloid plaque, they found.

Finally, they found that increasing levels of CatB in aging mice with human APP markedly reduced plaque deposits in the animals' brains.

Gan and colleagues concluded that "our findings suggest that inhibition or loss of CatB function could interfere with its protective function and promote the development of AD, whereas overexpression of CatB could counteract Aß accumulation and aggregation. Thus, pharmacological activation of CatB could downregulate Aß1-42 assemblies through C-terminal truncation, offering an approach to the treatment of AD."

Cell Press





Science News and Science Current Events Tag Cloud
This tag cloud is a visual representation of term frequencies of random science news topics with common terms grouped together and emphasized by their display size.
Search Engine   Apoptosis   Second-hand Smoke   Space Telescope   Carbon Footprint   Big Bang   Agriculture   Autoimmunity   Preterm Infants   Insulin Resistance   Bivalirudin   Behavior   Influenza Vaccine   Sleep   Ancient Egypt   Decision Making   Vitamin   Brain function   Pulsar   Amniotic Fluid   Neurodegeneration   Milky Way   Pathogen   Antimicrobial   Ulcerative Colitis  
Related Amyloid Current Events and Amyloid News Articles Amyloid Current Events and Amyloid News RSS Amyloid Current Events and Amyloid News RSS
Blood stem cell growth factor reverses memory decline in mice
A human growth factor that stimulates blood stem cells to proliferate in the bone marrow reverses memory impairment in mice genetically altered to develop Alzheimer's disease, researchers at the University of South Florida and James A. Haley Hospital found.

Alzheimer's research yields potential drug target
Scientists at UC Santa Barbara and several other institutions have found laboratory evidence that a cluster of peptides may be the toxic agent in Alzheimer's disease. Scientists say the discovery may lead to new drugs for the disease.

X-Rays for Early Alzheimer's Disease Detection
Researchers at the U.S. Department of Energy's (DOE) Brookhaven National Laboratory have demonstrated a new, highly detailed x-ray imaging technique that could be developed into a method for early diagnosis of Alzheimer's disease.

PET Scans May Improve Accuracy of Dementia Diagnosis
A new study shows that the use of positron emission tomography (PET) scans may improve the accuracy of dementia diagnoses early in disease onset for more than one out of four patients.

Popular Alzheimer's theory may be false trail
The idea that anti-inflammatory drugs might protect people struggling with dementia from Alzheimer's disease has received a blow with the online release of a study of human brain tissue in Acta Neuropathologica.

Scripps Florida scientists devise accelerated method to determine infectious prion strainsScripps Florida scientists devise accelerated method to determine infectious prion strains
Current tests to identify specific strains of infectious prions, which cause a range of transmissible diseases (such as mad cow) in animals and humans, can take anywhere from six months to a year to yield results - a time-lag that may put human populations at risk.

Researchers identify biological markers that may indicate poor breast cancer prognosis
A team of researchers has found an association between breast cancer survival and two proteins that, when present in the blood in high levels, are indicators of inflammation.

Automated analysis of MR images may identify early Alzheimer's disease
Analyzing MRI studies of the brain with software developed at the Martinos Center for Biomedical Imaging at Massachusetts General Hospital (MGH) may allow diagnosis of Alzheimer's disease and of mild cognitive impairment, a lesser form of dementia that precedes the development of Alzheimer's by several years.

Vaccine slows progression of skeletal muscle disorder
A potential vaccine for Alzheimer's disease also has been shown in mice to slow the weakening of muscles associated with inclusion body myositis, a disorder that affects the elderly.

Connections between diabetes and Alzheimer's disease explored
Modern societies face the increasing burden of age-related diseases, in particular Alzheimer's disease (AD) and type 2 diabetes (T2D).
More Amyloid Current Events and Amyloid News Articles
Amyloid Proteins: The Beta Sheet Conformation and Disease

Amyloid Proteins: The Beta Sheet Conformation and Disease
by Jean D. Sipe (Editor)

A first-stop reference on proteins associated with amyloidosis.
This book is the first to present a systematic overview of all known fibril-forming proteins, including their biochemical characteristics and pathophysiology. It considers the clinically recognized amyloid proteins that are known to be associated with the amyloid protein folding disorders, dealing with their common structural and thermodynamic features that lead to amyloid fibril formation and disease. Emphasis is on the thermodynamics of protein folding, the structure and physiologic effects of common oligomeric and subfibrillar intermediates and the influence of the extracellular matrix and cellular trafficking and metabolism on the genesis and catabolism of beta pleated sheet proteins.
The chapters on...

Amyloid, Prions, and Other Protein Aggregates, Part B, Volume 412

Amyloid, Prions, and Other Protein Aggregates, Part B, Volume 412
by Academic Press

The ability of polypeptides to form alternatively folded, polymeric structures such as amyloids and related aggregates is being increasingly recognized as a major new frontier in protein research. This new volume of Methods in Enzymology along with Part C (volume 413) on Amyloid, Prions and other Protein Aggregates continue in the tradition of the first volume (309) in containing detailed protocols and methodological insights, provided by leaders in the field, into the latest methods for investigating the structures, mechanisms of formation, and biological activities of this important class of protein assemblies.

* Presents detailed protocols
* Includes troubleshooting tips
* Provides coverage on structural biology, computational...

The NewsHour Reports on Alzheimer's Disease

The NewsHour Reports on Alzheimer's Disease
Starring: Charlayne Hunter-Gault, Jim Lehrer, Susan Dentzer, Steven DeKosky, Ray Suarez
Also With: MacNeil / Lehrer Productions (Producer)

According to the Alzheimer's Association, as many as eight million Americans will be suffering from Alzheimer's by 2030 and 16 million by 2050. The NewsHour reports on treatments, vaccine development, research, the impact on caregivers and the growing incidence of early-onset Alzheimer's disease.

This product is manufactured on demand using DVD-R recordable media. Amazon.com's standard return policy will apply.

[beta]-amyloid Peptide (1-42), Human, Oncogene - Size 250 Ug - Model Pp69--25mg - Each (.25 Mg)

[beta]-amyloid Peptide (1-42), Human, Oncogene - Size 250 Ug - Model Pp69--25mg - Each (.25 Mg)
by Oncogene

[beta]-Amyloid Peptide (1-42), Human, Oncogene - Size 250 ug - Model PP69--25MG - Each (.25 MG) : Lyophilized.Synthetic peptide corresponding to amino acids 1-42 of the processed human amyloid peptide. Supplied in a form that is not neurotoxic prior to preincubation. The level of toxicity has recently been shown to correlate to the extent of beta sheet structure. Reconstitute with degassed HPLC grade deionized water. Purity: >95% by HPLC. FW: 4 kDa.

Amyloid Proteins (Methods in Molecular Biology)

Amyloid Proteins (Methods in Molecular Biology)
by Einar M. Sigurdsson (Editor)

A proven collection of readily reproducible techniques for studying amyloid proteins and their involvement in the etiology, pathogenesis, diagnosis, and therapy of amyloid diseases. The contributors provide methods for the preparation of amyloid and its precursors (oligomers and protofibrils), in vitro assays and analytical techniques for their study, and cell culture models and assays for the production of amyloid proteins. Additional chapters present readily reproducible techniques for amyloid extraction from tissue, its detection in vitro and in vivo, as well as nontransgenic methods for developing amyloid mouse models. The protocols follow the successful Methods in Molecular Biology™ series format, each offering step-by-step laboratory instructions, an introduction outlining the...

Amyloid, Prions, and Other Protein Aggregates, Part B, Volume 412 (Methods in Enzymology)

Amyloid, Prions, and Other Protein Aggregates, Part B, Volume 412 (Methods in Enzymology)
by Ronald Wetzel (Editor), Indu Kheterpal (Editor)

The ability of polypeptides to form alternatively folded, polymeric structures such as amyloids and related aggregates is being increasingly recognized as a major new frontier in protein research. This new volume of Methods in Enzymology along with Part C (volume 413) on Amyloid, Prions and other Protein Aggregates continue in the tradition of the first volume (309) in containing detailed protocols and methodological insights, provided by leaders in the field, into the latest methods for investigating the structures, mechanisms of formation, and biological activities of this important class of protein assemblies.

* Presents detailed protocols
* Includes troubleshooting tips
* Provides coverage on structural biology, computational...

Amyloid Precursor Protein:  A Practical Approach

Amyloid Precursor Protein: A Practical Approach
by Taylor & Francis

In the search for an effective treatment for Alzheimer's disease, APP is a unique model protein that illustrates the wide array of basic and sophisticated characterization techniques available. Amyloid Precursor Protein: A Practical Approach presents a variety of biological techniques utilized in genetics, molecular biology, cell biology, and biochemistry to elucidate the structure and function of this transmembrane protein. Each technique is presented with detailed, step-by-step protocols to achieve reproducible results and provide a framework for studying other membrane proteins. These protocols also form the core of the authors' approach to elucidating the function of APP.



Amyloids, Prions and Other Protein Aggregates (Methods in Enzymology, Volume 309)

Amyloids, Prions and Other Protein Aggregates (Methods in Enzymology, Volume 309)
by John N. Abelson (Editor), Melvin I. Simon (Editor), Ronald Wetzel (Editor)

This volume includes a core of methodologies to attack the unique experimental problems presented by protein misassembly. Emphasis is on human biology applications, the area in which there is the most interest, in which most of the work has already been done, and in which there is the best evidence for the structural sophisitication of the protein aggregates.
The critically acclaimed laboratory standard for more than forty years, Methods in Enzymology is one of the most highly respected publications in the field of biochemistry. Since 1955, each volume has been eagerly awaited, frequently consulted, and praised by researchers and reviewers alike. Now with more than 300 volumes (all of them still in print), the series contains much material still relevant today--truly an essential...

Cerebral Amyloid Angiopathy in Alzheimer's Disease and Related Disorders

Cerebral Amyloid Angiopathy in Alzheimer's Disease and Related Disorders
by Springer

Cerebral amyloid angiopathy (CAA) is a distinctive abnormality of small cerebral blood vessels, one that has intrigued neuroscientists for decades. The time seems right for a book which examines the phenomenon of CAA using a multifaceted approach: What does it produce clinically? How might CAA be imaged? What are the crucial biochemical/cellular events within cerebral vessel walls that lead to CAA? How can in vitro or transgenic experimental systems be used to understand the etiology of, or even potential treatments for, CAA? The editors have assembled key figures in the field of CAA research to examine these (and other) questions in a series of focused chapters that address specific issues of importance in understanding CAA and its clinical manifestations. Comprehending the...

  ProteoTech receives issuance of United States patent covering treatments for human amyloid diseases.: An article from: BIOTECH Patent News
b

This digital document is an article from BIOTECH Patent News, published by Biotech Patent News on September 1, 2003. The length of the article is 5301 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: ProteoTech receives issuance of United States patent covering treatments for human amyloid diseases.
Publication: BIOTECH Patent News (Newsletter)
Date: September 1, 2003
Publisher: Biotech Patent News
Volume: 17 Issue: 9

Distributed by Thomson...

© 2009 BrightSurf.com